Berkley Capital, Llc Sells 350,000 Shares of Healthequity Inc (HQY) Stock

Healthequity Inc (NASDAQ:HQY) insider Berkley Capital, Llc sold 350,000 shares of the company’s stock in a transaction on Monday, February 12th. The shares were sold at an average price of $52.12, for a total value of $18,242,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Berkley Capital, Llc also recently made the following trade(s):

  • On Thursday, February 8th, Berkley Capital, Llc sold 100,000 shares of Healthequity stock. The shares were sold at an average price of $51.25, for a total value of $5,125,000.00.
  • On Wednesday, November 29th, Berkley Capital, Llc sold 700 shares of Healthequity stock. The shares were sold at an average price of $52.05, for a total value of $36,435.00.
  • On Monday, November 27th, Berkley Capital, Llc sold 12,300 shares of Healthequity stock. The shares were sold at an average price of $52.14, for a total value of $641,322.00.
  • On Wednesday, November 22nd, Berkley Capital, Llc sold 11,200 shares of Healthequity stock. The shares were sold at an average price of $51.54, for a total value of $577,248.00.
  • On Friday, November 24th, Berkley Capital, Llc sold 77,221 shares of Healthequity stock. The shares were sold at an average price of $51.31, for a total value of $3,962,209.51.
  • On Thursday, November 16th, Berkley Capital, Llc sold 23,479 shares of Healthequity stock. The shares were sold at an average price of $51.08, for a total value of $1,199,307.32.

Shares of Healthequity Inc (NASDAQ HQY) traded up $1.36 during mid-day trading on Monday, hitting $52.65. The stock had a trading volume of 979,509 shares, compared to its average volume of 475,368. The company has a market capitalization of $3,190.00, a PE ratio of 71.15, a PEG ratio of 1.96 and a beta of 1.70. Healthequity Inc has a 12 month low of $37.62 and a 12 month high of $55.31.

Healthequity (NASDAQ:HQY) last announced its earnings results on Tuesday, December 5th. The company reported $0.17 EPS for the quarter, topping the consensus estimate of $0.13 by $0.04. The company had revenue of $56.80 million for the quarter, compared to analysts’ expectations of $55.27 million. Healthequity had a return on equity of 14.47% and a net margin of 21.08%. The business’s revenue for the quarter was up 31.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.10 earnings per share. sell-side analysts anticipate that Healthequity Inc will post 0.73 earnings per share for the current year.

A number of analysts have weighed in on the company. BidaskClub upgraded Healthequity from a “sell” rating to a “hold” rating in a research report on Tuesday, November 7th. Zacks Investment Research upgraded Healthequity from a “hold” rating to a “buy” rating and set a $57.00 target price on the stock in a report on Saturday. JPMorgan Chase & Co. decreased their target price on Healthequity from $52.00 to $51.00 and set an “overweight” rating on the stock in a report on Wednesday, January 24th. Cantor Fitzgerald increased their target price on Healthequity from $56.00 to $60.00 and gave the stock an “overweight” rating in a report on Wednesday, February 7th. Finally, Robert W. Baird increased their target price on Healthequity from $48.00 to $49.00 and gave the stock a “neutral” rating in a report on Wednesday, February 7th. Two investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $56.67.

A number of institutional investors have recently bought and sold shares of HQY. UBS Asset Management Americas Inc. boosted its holdings in Healthequity by 24.3% in the second quarter. UBS Asset Management Americas Inc. now owns 28,342 shares of the company’s stock valued at $1,412,000 after acquiring an additional 5,544 shares during the last quarter. Northern Trust Corp boosted its holdings in Healthequity by 14.1% in the second quarter. Northern Trust Corp now owns 662,459 shares of the company’s stock valued at $33,010,000 after acquiring an additional 81,665 shares during the last quarter. Vanguard Group Inc. boosted its holdings in Healthequity by 3.0% in the second quarter. Vanguard Group Inc. now owns 4,237,298 shares of the company’s stock valued at $211,145,000 after acquiring an additional 122,061 shares during the last quarter. California Public Employees Retirement System boosted its holdings in Healthequity by 2.2% in the second quarter. California Public Employees Retirement System now owns 92,200 shares of the company’s stock valued at $4,594,000 after acquiring an additional 2,000 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its holdings in Healthequity by 25.3% in the second quarter. Dimensional Fund Advisors LP now owns 473,433 shares of the company’s stock valued at $23,591,000 after acquiring an additional 95,514 shares during the last quarter. Institutional investors and hedge funds own 98.63% of the company’s stock.

WARNING: This report was first posted by American Banking News and is owned by of American Banking News. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international copyright and trademark law. The original version of this report can be accessed at https://www.americanbankingnews.com/2018/02/12/berkley-capital-llc-sells-350000-shares-of-healthequity-inc-hqy-stock.html.

Healthequity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Insider Buying and Selling by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply